EG 427 is a biotechnology company leading the development of pinpoint DNA medicine solutions. It has developed a non-replicative Herpes Simplex Virus type 1 (nrHSV-1) based vector platform which delivers, with pinpoint precision, highly selective, durable expression of disease-modifying transgenes. The company leverages the technology to design new treatments for peripheral nervous system disorders and …

A spin-out of the Ophthalmology Department of the University Medical Center Groningen, Reyedar (previously known as Reperio Medtech) uses eye-tracking sensors coupled with deep learning to detect early symptoms of age-related degenerative diseases such as glaucoma, Parkinson’s, and multiple sclerosis. Early diagnosis is expected to improve the outcome of treatment and also healthcare costs. Reyedar …

A spin-off of the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, INBRAIN Neuroelectronics is a medical device company dedicated to developing the world’s first intelligent graphene-brain interface to treat a variety of conditions. INBRAIN’s less-invasive graphene electrodes take advantage of some of graphene’s unique properties to enable ultra-high signal resolution at levels never …